Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer
- 1st Edition - January 31, 2019
- Editor: Prashant Kesharwani
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 1 5 7 2 0 - 6
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 6 3 6 7 - 2
Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and devel… Read more
Purchase options
Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.
- Provides an overview of an array of nanotechnology-based drug delivery systems
- Examines the design, synthesis and application of different nanocarriers in drug and gene delivery
- Provides an in-depth understanding of the design of targeted nanotherapeutics and technologies and its implication in various site-specific cancers
Pharmaceutical scientists, clinical researchers especially cancer researchers, biomedical and biotechnology professionals, graduate students and academic researchers in pharmaceutical science and materials science working in drug delivery and nanotechnology
PrefacePrashant Kesharwani1. Introduction: An Overview of the anatomy and physiology of the lungShadab Md2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug ResistanceChitra Thakur3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancerBapi Gorain4. Polymeric nanoparticles based drug delivery for lung cancerLipika Ray5. Solid lipid nanoparticles based drug delivery for lung cancerAhmed Elzoghby6. Liposomes and niosomes based drug delivery for lung cancerPaulina Skupin-Mrugalska7. Dendrimers based drug delivery for lung cancerPrashant Kesharwani8. Micelles based drug delivery for lung cancerKhaled Greish9. Nanoemulsions based drug delivery for lung cancerHira Choudhury10. Nanomedicine-based inhalation treatments for lung cancerRémi Rosière11. Towards development of novel diagnostic nano-imaging platform for lung cancerZahid Hussain12. Hydrogel based drug delivery for lung cancerVijay Mishra13. Quantum dots based drug delivery for lung cancerVijay Mishra
- Edition: 1
- Published: January 31, 2019
- Language: English
PK
Prashant Kesharwani
Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “SERB-Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community. His Number of citations is = 26779; h-index = 85; i-10 index = 370 (According to google scholar on March 2025). He has more than 30 international publications published in very high impact factor journals (Progress in Polymer Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug Resistance Update IF 22.841 and Material Todays IF 32.072). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.
Affiliations and expertise
Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, IndiaRead Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer on ScienceDirect